CNR Institutional Research Information System

IOMMELLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.610
NA - Nord America 902
EU - Europa 438
SA - Sud America 220
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 16
OC - Oceania 1
Totale 3.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 842
SG - Singapore 633
CN - Cina 333
HK - Hong Kong 269
BR - Brasile 173
IT - Italia 157
VN - Vietnam 130
FR - Francia 92
JP - Giappone 58
KR - Corea 57
NL - Olanda 55
BD - Bangladesh 54
FI - Finlandia 35
CA - Canada 30
DE - Germania 30
GB - Regno Unito 22
IN - India 21
AR - Argentina 20
MX - Messico 14
EC - Ecuador 10
ES - Italia 10
IQ - Iraq 8
CO - Colombia 7
IL - Israele 7
RU - Federazione Russa 7
ZA - Sudafrica 7
ID - Indonesia 6
IE - Irlanda 5
TR - Turchia 5
KH - Cambogia 4
PH - Filippine 4
UA - Ucraina 4
UZ - Uzbekistan 4
AT - Austria 3
JO - Giordania 3
LV - Lettonia 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CL - Cile 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
Totale 3.187
Salva come PNG Salva come JPEG
Città #
Singapore 397
Santa Clara 290
Hong Kong 267
Hefei 115
San Jose 104
Beijing 90
Ashburn 78
Lauterbourg 68
Naples 61
Seoul 57
Tokyo 50
Ho Chi Minh City 47
Hanoi 33
Los Angeles 30
New York 21
Lappeenranta 17
São Paulo 17
Frankfurt am Main 15
Helsinki 14
Casandrino 13
Buffalo 9
Council Bluffs 9
Dallas 8
Rome 8
Brooklyn 7
Chicago 7
Milan 7
Orem 7
Belleville 6
Bengaluru 6
Boardman 6
Mexico City 6
Minamishinagawa 6
Rio de Janeiro 6
Atlanta 5
Belo Horizonte 5
Da Nang 5
Des Moines 5
Dublin 5
Guayaquil 5
Hangzhou 5
London 5
Amsterdam 4
Baghdad 4
Buenos Aires 4
Carapicuíba 4
Düsseldorf 4
Ercolano 4
Istanbul 4
Miami 4
Montreal 4
Phnom Penh 4
Phoenix 4
Poplar 4
Porto Alegre 4
Tashkent 4
Turku 4
Biên Hòa 3
Can Tho 3
Chennai 3
Duque de Caxias 3
Ha Long 3
Haiphong 3
Johannesburg 3
Las Vegas 3
Munich 3
Paris 3
Phủ Lý 3
Quito 3
Riga 3
Salvador 3
Shanghai 3
Toronto 3
Vitória da Conquista 3
Abidjan 2
Abingdon 2
Amman 2
Baku 2
Bauru 2
Bonito 2
Boston 2
Brasília 2
Bratislava 2
Charlotte 2
Chongqing 2
City of London 2
Clinton Township 2
Columbus 2
Covina 2
Dhaka 2
Elk Grove Village 2
Erbil 2
Falkenstein 2
Florence 2
Fortaleza 2
Franco da Rocha 2
Guangzhou 2
Hammond 2
Houston 2
Hyderabad 2
Totale 2.085
Salva come PNG Salva come JPEG
Nome #
Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT 90
Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) 88
Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation. 88
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 75
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 74
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study 71
Molecular mechanisms of decreased aerobic glycolysis in non-small lung cancer treated with EGFR tyrosine kinase inhibitors. European Society for Molecular Imaging Meeting 70
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 69
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 67
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 66
18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors 66
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art 64
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 63
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 62
Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib 60
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 60
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 57
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 56
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 56
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 56
A reversible shift of driver dependence from egfr to notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 55
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 54
Preclinical imaging for targeting cancer immune evasion 52
Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC 52
Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells 52
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells 47
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 46
Preclinical Imaging in Targeted Cancer Therapies 46
Notch1-dependent targets in cancer stem cell resistance to EGFR inhibitors in oncogene-driven non-small cell lung cancer 44
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins 44
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 44
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 43
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 42
PET/CT in cancer research: from preclinical to clinical applications 41
99mTc-MIBI in the evaluation of breast cancer biology 41
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 40
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 40
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 39
Preclinical imaging in oncology: advances and perspectives 39
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 37
Early F-18-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 35
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System 35
Evaluation of experimental pulmonary metastases in murine models by x-ray micro-computed tomography 35
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 34
Molecular imaging of drug resistance in cancer 34
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer. 33
99mTc-MIBI in the evaluation of breast cancer biology 33
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 32
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 31
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer 30
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 30
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 29
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 29
Stato dell'arte dell'imaging preclinico in oncologia 29
18F-FLT PET/CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC 29
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 28
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 28
18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 28
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 28
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 28
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer 27
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 27
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 27
Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells 27
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)—A Preliminary In Vitro Study 26
[18]F-FLT PET-CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC. 26
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 26
PET/CT in cancer research: from preclinical to clinical applications 24
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer 24
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 23
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 23
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 22
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 21
Addition of metformin to anti-PD-1/PD-L1 drugs activates antitumor immune response in peripheral immune cells of NSCLC patients 21
Molecular imaging of tumor microenvironment: challenges and perspectives 21
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC 21
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 13
Totale 3.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.699
article - articoli 8.723
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 248
Totale 19.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202445 0 0 0 0 0 0 0 0 4 13 13 15
2024/20251.214 14 13 106 58 293 51 14 73 59 79 239 215
2025/20261.900 95 151 121 204 430 105 281 78 149 125 79 82
2026/2027114 114 0 0 0 0 0 0 0 0 0 0 0
Totale 3.273